MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 137 filers reported holding MERSANA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $142,517 | -77.1% | 112,218 | -40.8% | 0.00% | – |
Q2 2023 | $623,697 | -63.8% | 189,611 | -54.8% | 0.00% | -100.0% |
Q1 2023 | $1,723,325 | +59967.1% | 419,337 | -14.4% | 0.00% | 0.0% |
Q4 2022 | $2,869 | -99.9% | 489,783 | -0.5% | 0.00% | 0.0% |
Q3 2022 | $3,329,000 | +245.0% | 492,488 | +135.6% | 0.00% | – |
Q2 2022 | $965,000 | +30.1% | 209,060 | +12.4% | 0.00% | – |
Q1 2022 | $742,000 | -38.7% | 186,040 | -4.4% | 0.00% | – |
Q4 2021 | $1,210,000 | -31.6% | 194,516 | +3.7% | 0.00% | -100.0% |
Q3 2021 | $1,768,000 | -26.0% | 187,516 | +6.5% | 0.00% | 0.0% |
Q2 2021 | $2,390,000 | -17.4% | 176,004 | -1.6% | 0.00% | 0.0% |
Q1 2021 | $2,894,000 | -40.3% | 178,843 | -1.8% | 0.00% | -50.0% |
Q4 2020 | $4,844,000 | +33.3% | 182,048 | -6.8% | 0.00% | 0.0% |
Q3 2020 | $3,635,000 | -22.0% | 195,231 | -1.9% | 0.00% | 0.0% |
Q2 2020 | $4,659,000 | +297.2% | 199,107 | -1.0% | 0.00% | +100.0% |
Q1 2020 | $1,173,000 | +103.6% | 201,136 | +100.2% | 0.00% | – |
Q4 2019 | $576,000 | +487.8% | 100,472 | +61.3% | 0.00% | – |
Q3 2019 | $98,000 | -27.4% | 62,291 | +86.4% | 0.00% | – |
Q2 2019 | $135,000 | – | 33,422 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 1,191,271 | $6,980,848 | 6.79% |
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $50,769 | 5.67% |
ACUTA CAPITAL PARTNERS, LLC | 950,000 | $5,567,000 | 3.43% |
Sarissa Capital Management LP | 3,997,010 | $23,422,479 | 2.79% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $5,299,010 | 1.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,140,182 | $6,681,467 | 1.91% |
Orbimed Advisors | 9,011,437 | $52,807,021 | 1.01% |
Opaleye Management Inc. | 460,000 | $2,695,600 | 0.94% |
Artal Group S.A. | 2,200,000 | $12,892 | 0.72% |
DAFNA Capital Management LLC | 413,463 | $2,422,893 | 0.68% |